Articles tagged with Tuberculosis
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A research article compares CT findings in mesenteric tuberculosis and non-Hodgkin's lymphoma (NHL), revealing specific enhancement patterns and anatomic lymph node distribution. The 'sandwich sign' is more often found in NHL, aiding in differential diagnosis between tuberculosis and untreated NHL involving the small bowel mesentery.
Researchers tested two Ayurvedic herbs, Curcuma longa and Tinospora cordifolia, in a clinical trial to evaluate their ability to prevent hepatotoxicity. The results showed that the formulation was safe and effective in preventing liver damage, with only 0.06% incidence of mild hepatotoxicity compared to 14% in the control group.
A team of Michigan Tech researchers is harnessing video game technology to model complex biological systems, such as the human immune response to tuberculosis. Using GPUs, they have created a powerful new tool for medical research, allowing for faster and more efficient simulations of diseases like sepsis.
Research found that only 8.5% of patients accounted for 98% of guinea pig TB infections, highlighting the high infectiousness of inadequately treated drug-resistant TB patients. Implementing TB infection control measures can prevent airborne transmission in healthcare facilities.
A new study reveals that an investigational drug, R207910, is effective in killing latent tuberculosis bacteria. The drug targets a protein essential for energy production in active TB, suggesting a potential Achilles heel for dormant bacteria.
African countries are grappling with a growing number of chronic infectious and non-communicable diseases due to scale-up of antiretroviral therapy for HIV. Mortality from all-cause diseases increased by 87% between 1992 and 2005, primarily due to rising deaths from infectious disease affecting both sexes.
Researchers found that aggressive treatment with at least five effective drugs can cure XDR TB, reversing the chronic features of the disease in many patients. This approach also prevents high mortality rates and further transmission of drug-resistant strains.
Despite being an important part of TB control efforts, children are underrepresented in TB drug development. Key findings include: Children make up 20% of new TB cases and are at high risk of severe TB forms. The lack of child involvement is due to barriers such as diagnostic challenges, side effect concerns, and regulatory requirements.
California officials have identified 18 cases of extensively drug-resistant tuberculosis (XDR TB) between 1993 and 2006. The state has also seen a rising trend of multidrug-resistant tuberculosis (MDR TB) cases, with XDR TB being resistant to multiple classes of antibiotics.
A study conducted in Peru found that more than 60% of XDR-TB patients were cured after receiving personalized outpatient therapy. The ambulatory model showed better outcomes than hospital settings and has the potential to be widely implemented in resource-poor settings.
A study of 174 tuberculosis patients found that extensively drug-resistant TB patients were almost eight times as likely to die as those with multi-drug resistant TB. The study emphasizes the critical importance of optimal management of multi-drug resistant cases to prevent progression to XDR-TB and associated poorer outcomes.
A study published in JAMA Network found that patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy. In contrast, efavirenz-based ART was associated with similar virological suppression rates regardless of tuberculosis status.
Current TB treatment regimens are insufficient in countries with high MDR-TB prevalence, leading to significantly higher failure and relapse rates. Studies reveal that for every 1% increase in MDR-TB, there's a corresponding 0.3% rise in new case treatment failure and a 1.1% increase in retreatment failure rate.
Researchers at Weill Cornell Medical College have identified a key membrane protein, Rv3671c, essential to Mycobacterium tuberculosis' defense against immune cell acidification. Disabling this protein makes the bacterium vulnerable to acidification and killing.
Researchers propose integrating TB prevention and treatment into HIV care to address the major cause of mortality among HIV patients. The authors recommend intensified TB case finding, preventive isoniazid therapy for non-TB infected HIV patients, and earlier provision of antiretroviral therapy.
TB is a threat throughout the course of HIV disease, and addressing it is crucial for saving patient lives and curbing the global TB burden. The authors propose several strategic approaches, including intensified case finding, treating individuals with active TB, and implementing infection control measures.
A study published in PLOS ONE found that bovine tuberculosis is prevalent among wild boar, red deer, and fallow deer in Doñana National Park, threatening the health of endangered lynx and domestic cattle. The high prevalence suggests that a feeding ban alone would have limited effect on controlling the disease.
A study identifies US foreign-born persons from certain regions as being at a higher risk of contracting and spreading tuberculosis. The research highlights the need for targeted TB control strategies to address the growing burden of latent TB infection in this population.
A study by David Stuckler and colleagues found that International Monetary Fund loans were associated with a 16.6% rise in death rates from tuberculosis (TB) in the former Soviet Union and Central and Eastern European countries between 1992 and 2002.
Researchers from KEMRI-Wellcome Trust Research Programme assess rotavirus diarrhoea in young children, finding over 2% hospital admissions. Meanwhile, PLOS Medicine article discusses evidence-based TB diagnosis, citing the importance of strong evidence backing expenditure on diagnostics.
A systematic review of 13 observational studies found that diabetes mellitus increases the risk of active tuberculosis by about a factor of three, suggesting a possible role in over 10% of TB cases in India and China.
Six-thousand year old Jericho bones excavated by Dr. Kathleen Kenyon will be tested for tuberculosis, leprosy, and malaria to better understand disease development and transmission.
A third of the world's population is infected with M. tuberculosis, and two million people die from tuberculosis every year. New, improved vaccines or vaccination strategies are urgently needed to reduce the immense burden of this disease.
MDR-TB experts recommend new tools for testing, clinical trials of simplified treatments, and improved diagnosis strategies to overcome barriers. Pilot projects show promising results in low-income settings with treatment success rates of 59-83%.
Researchers have identified a new target for TB treatment, solving a long-standing puzzle about bacterial cell wall production. The discovery reveals molecules that could be developed into drugs to treat tuberculosis, particularly for multi-drug resistant strains.
Researchers found that if the first two TB patients are diagnosed within three months of each other, especially in urban areas with sub-Saharan African origin, there's a 56% chance of an outbreak. This information can help focus public health resources more efficiently.
Researchers Francesco Checchi and Les Roberts argue that an independent body is needed to accurately document death rates during humanitarian emergencies. Such a body could provide a basis for both humanitarian advocacy and political advocacy, and could help prevent the DRC experience from being repeated.
Researchers discovered that TB bacteria can form biofilms on surfaces, leading to genetic and physiological differences from lab-grown strains. This finding suggests a possible cause of TB relapses despite intensive treatment.
Researchers suggest that increasing white blood cell count or enhancing infected cells' interaction with the immune system could be effective strategies for developing vaccines or treatments specifically for elderly TB patients. Aging affects the immune response, leading to a slower and less effective fight against the infection.
Sub-Saharan Africa faces frequent stock interruptions of essential drugs for managing non-communicable diseases. Implementing standardized approaches to NCD management, as seen in TB control, can improve patient care and outcomes. A five-point framework called DOTS provides lessons for NCD control.
A growing number of 'pseudoepidemics' of false-positives for TB are occurring in the US Army due to universal testing with an inaccurate TST. The problem is most prevalent in regions with high TB rates, such as Iraq and Afghanistan.
A new TB treatment using Rifampin for four months is more effective than the current nine-month standard, saving healthcare systems $10,000 per patient. This shorter treatment also leads to better compliance rates and lower costs.
A new analysis of REMICADE for ulcerative colitis found that over 60% of patients achieved clinical response at week 8, with significant improvements maintained at week 30. The study also reported significant improvements in disease remission and mucosal healing.
A survey of infectious diseases physicians found that patients taking immune-modulating therapies are at risk for nontuberculosis mycobacterial infections, histoplasmosis, and invasive S. aureus infections. Clinicians should be vigilant for these infections, particularly in patients with underlying lung disease.
Researchers at the University of British Columbia have discovered how tuberculosis bacteria hide and multiply in human bodies. By identifying a key protein involved in this process, they are working towards therapies that can block its activity, leading to a more effective treatment for TB.
A new study from researchers at the University of Alabama at Birmingham found that carbon monoxide in air pollution and tobacco smoke triggers tuberculosis infection to shift into a dormant state. This dormant state is difficult to detect and treat, contributing to the spread of TB and its high mortality rate.
Researchers found that a portable anteroom HEPA filtration unit can effectively remove airborne microorganisms, including M. tuberculosis, from operating rooms. The study suggests that this unit can help prevent secondary transmission of airborne pathogens and improve patient and healthcare personnel safety.
Researchers have elucidated the mechanism of iron uptake system in M. tuberculosis, a promising target for intervention. The study reveals an exporter-importer system that exports siderophores and imports iron-bound forms, providing a crucial foothold to tame this deadly pathogen.
A study found that micronutrient supplementation reduced TB recurrence rates in patients undergoing chemotherapy. The study showed a 45% overall reduction and a 63% decrease for HIV-infected patients.
The National Institute of Allergy and Infectious Diseases (NIAID) has outlined a research agenda to combat drug-resistant tuberculosis, a major public health concern. The agenda focuses on developing reliable diagnostics, testing new drugs, and understanding the biology of TB-causing bacteria.
Rachel L. Stricof, a leading expert in infection prevention, has been recognized with the prestigious Carole DeMille Achievement Award for her dedication to improving health and patient safety. With over 30 years of experience, she has established innovative reporting systems and collaborated with policymakers to reduce HAI rates.
A new rapid diagnostic test can detect multidrug-resistant tuberculosis (MDR-TB) in high-burden settings like public health clinics more quickly and accurately than conventional methods. This improvement enables proper treatment to begin promptly, reducing the risk of transmission.
Researchers have developed an assay to identify antibodies specific to Mycobacterium avium complex (MAC), distinguishing MAC-related pulmonary disease from tuberculosis in under eight hours. The test showed high sensitivity and specificity, reducing the risk of misdiagnosis and inappropriate treatment.
Researchers at the University of Leicester have discovered that TB bacteria accumulate body fat to aid survival during transmission, increasing resistance to anti-TB drugs. This finding challenges established views on bacterial transmission and offers new insights into developing targeted treatments.
Researchers identified a genetic variant associated with severe tuberculosis (TB) in Vietnam, highlighting the importance of studying host-pathogen interactions. The study suggests that understanding genetic susceptibility to infectious diseases may lead to more targeted treatments and vaccines.
The University of Pittsburgh Center for Vaccine Research has received a $11.4 million grant to study tuberculosis using new imaging technologies. The goal is to develop more effective treatments that can be tailored to individual patients, potentially improving survival rates and curtailing the global TB epidemic.
Researchers at the University of Leicester have discovered how TB bacteria becomes resistant to isoniazid, a key treatment for the disease. The study reveals that mutations in bacterial enzymes protect it from the treatment, highlighting the importance of understanding drug resistance.
A new aerosol version of the most common TB vaccine administered directly to the lungs via oral mist provides significantly better protection against TB in experimental animals. The vaccine could offer a safer, more consistent treatment option with reduced need for refrigerated storage.
A new blood test, ELISpot-Plus, in conjunction with a skin test, can rule out tuberculosis infection within 48 hours, providing a much quicker result than existing methods. This combination enables doctors to diagnose TB more accurately and begin investigating other possible explanations for patients' symptoms.
A new TB screening test based on ELISPOT test has shown high sensitivity and specificity in detecting latent TB infection in HIV-infected individuals. The test was compared to the traditional tuberculin skin test (TST) and found to be more sensitive, but its effectiveness in severely immunosuppressed individuals remains unclear.
A new guideline for treating dementia emphasizes the importance of individualized assessment and treatment based on a patient's specific medication regimen. Researchers also developed two new blood tests to diagnose latent tuberculosis, finding that one test is more sensitive than traditional methods.
A six-year vitamin E supplementation increased TB risk by 72% in male smokers with high dietary vitamin C intake. Vitamin E had no effect on those with low dietary vitamin C intake.
India is experiencing a devastating tobacco-related disease crisis, with approximately 1 million deaths expected each year from 2010 to 2019. The study reveals that smoking causes nearly one in five male deaths and one in twenty female deaths at ages 30-69.
The US is likely to miss its goal of eliminating tuberculosis by 2010 due to high latent TB infection rates among certain groups, including those living below the poverty line and foreign-born individuals.
The grant will support research into the proteins on TB bacteria's surface that are vital for infection, aiming to develop a map for drug developers. The goal is to create a new family of TB drugs that can effectively target the disease in a new way.
Researchers have developed a key small molecule inhibitor targeting 'virulence factors' used by bacteria to thrive, offering an alternative means of stopping TB, leprosy, and other bacterial illness. The findings highlight a paradigm shift in infectious disease research beyond antimicrobials like antibiotics.
A Cornell research team used gene chips to study Mycobacterium tuberculosis and found that the bacteria's genes are activated after being engulfed by a macrophage. The study also compared the responses of M. tuberculosis to BCG, finding that BCG may be less capable of protecting itself once inside a macrophage.
A new study from Yale University suggests that preventing half of new XDR TB cases can be achieved through inexpensive infection control measures, including reducing hospital overcrowding and improving ventilation. This could potentially save millions of lives globally.
Researchers have found that rifapentine, an older antibiotic, is a potent treatment for tuberculosis when used at high doses. Clinical trials are underway to test its effectiveness in reducing treatment time from six months to three months or less.
Weill Cornell Medical College has received grants to develop innovative TB drugs and treatments, with a focus on killing or interfering with the TB organism in its non-replicating phase. The research aims to shorten TB therapy from six months to just a couple of weeks, while also addressing emerging drug-resistant forms.